Abstract
Phenylketonuria (PKU) and hyperphenylalaninemia (HPA) are caused mostly by an inherited (autosomal recessive) deficiency in hepatic phenylalanine hydroxylase (PAH) activity. More than 50 PAH mutations have ben reported. The goal of the present study was to examine the molecular basis for the clinical heterogeneity of Swedish PKU and HPA patients. Mutations were identified through allele-specific oligonucleotide hybridization or DNA sequencing on 128 of the 176 mutant alleles (73%). Three mutations (R408W, Y414C and IVS12) together accounted for 56% of all mutant alleles and ten relatively infrequent mutations were found on another 17% of all mutant alleles. Patients from 50 of the 88 families (57%) had identified mutations in both PAH genes and allowed use to compare the clinical effects of different combinations of PAH mutations. The in vitro activity of all of these mutations, including the newly identified G272X and ΔL364, have been tested in a eukaryotic expression system. There was a strong relationship between the average in vitro PAH activity of the two mutant enzymes and both the phenylalanine tolerance and the neonatal pretreatment serum phenylalanine concentration. This confirms previous observations in Danish and German PKU patients that disease phenotype is a consequence of the nature of the mutations at the PAH locus and not significantly influenced by other loci. The sample population in the previous study did not, however, include mild HPA patients, and the observed correlation is thus restricted to severe and moderate mutant alleles. Since a comparatively high proportion of the Swedish patients were mildly affected, we have provided additional evidence that this correlation is valid throughout a continuous spectrum of clinical varieties. PAH genotyping could therefore help predict prognosis of a recently diagnosed PKU or HPA child.
Similar content being viewed by others
Abbreviations
- ASO:
-
allele-specific oligonucleotide
- HPA:
-
hyperphenylalaninemia
- PAH:
-
phenylalanine hydroxylase
- PKU:
-
phenylketonuria
References
Berthelon M, Caillaud C, Rey F, Labrune P, Melle D, Feingold J, Frézal J, Briard M-L, Farriaux J-P, Guibaud P, Journel H, Le Marec B, Maurin N, Nivelon J-L, Plauchu H, Saudubray J-M, Tron P, Rey J, Munnich A, Lyonnet S (1991) Spectrum of phenylketonuria mutations in Western Europe and North Africa, and their relation to polymorphic DNA haplotypes at the phenylalanine locus. Hum Genet 86:355–358
Caillaud C, Lyonnet S, Rey F, Melle D, Frebourg T, Berthelon M, Vilarinho L, Osorio RV, Rey J, Munnich A (1991) A 3-base pair in-frame deletion of the phenylalanine hydroxylase gene results in a variant of phenylketonuria. J Biol Chem 266: 9351–9354
Chakraborty R, Lidsky AS, Daiger SP, Güttler F, Sullivan S, DiLella AG, Woo SLC (1987) Polymorphic DNA haplotypes at the human phenylalanine hydroxylase locus and their relationship with phenylketonuria. Hum Genet 76:40–46
Dasovich M, Eisensmith RC, Okano Y, Wang T, Woo SLC (1990) Multiple founding origins of PKU in Europe [abstract]. Am J Hum Genet 47 [Suppl]:A131
Dasovich M, Konecki D, Lichter-Konecki U, Eisensmith RC, Güttler F, Naughton E, Mullins C, Giovanni M, Ria E, Woo SLC (1991) Molecular characterization of PKU allele prevalent in Southern Europe and Ireland. Somat Cell Mol Genet 17:303–309
DiLella AG, Woo SLC (1987) Hypbridization of genomic DNA to oligonucleotide probes in the presence of tetramethylammonium chloride. Methods Enzymol 152:447–451
DiLella AG, Marvit J, Lidsky AS, Güttler F, Woo SLC (1986) Tight linkage between a splicing mutation and a specific DNA haplotype in phenylketonuria. Nature 322:799–803
DiLella AG, Marvit J, Brayton K, Woo SLC (1987) An aminoacid substitution involved in phenylketonuria is in linkage disequilibrium with DNA haplotype 2. Nature 327:333–336
Dworniczak B, Grudda K, Stümper J, Bartholomé K, Aulehla-Scholz C, Horst J (1991) Phenylalanine hydroxylase gene: novel missense mutations in exon 7 causing severe phenylketonuria. Genomics 9:193–199
Eisensmith RC, Woo SLC (1992) Molecular basis of phenylketonuria and related hyperphenylalaninemias: mutations and polymorphisms in the human phenylalanine hydroxylase gene. Hum Mutation (in press)
Güttler F, Ledley FD, Lidsky AS, DiLella AG, Sullivan S, Woo SLC (1987) correlation between polymorphic DNA haplotypes at phenylalanine hydroxylase locus and clinical phenotypes of phenylketonuria. J Pediatr 110:68–71
John SWM, Rosen R, Scriver CR, Laframboise R, Laberge C (1990) Recurrent mutation, gene conversion, or recombination at the human phenylalanine hydroxylase locus and clinical phenotpyes of phenylketonuria. J Pediatr 110:68–71
Kwok SCM, Ledley FD, DiLella AG, Robson KJH, Woo SLC (1985) Nucleotide sequence of a full-length complementary DNA clone and amino acid sequence of human phenylalanine hydroxylase. Biochemistry 24:556–561
Ledley FD, Grenett HE, DiLella AG, Kwok SCM, Woo SLC (1985) Gene transfer and expression of human phenylalanine hydroxylase. Science 228:77–79
Ledley FD, Grenett HE, Woo SLC (1987) Biochemical characterization of recombinant human phenylalanine hydroxylase produced inEscherichia coli. J Biol Chem 262:2228–2233
Lichter-Konecki U, Konecki DS, DiLella AD, Brayton D, Marvit J, Hahn TM, Trefz FK, Woo SLC (1988) Phenylalanine hydroxylase deficiency caused by a single base substitution in an exon of the human phenylalanine hydroxylase gene. Biochemistry 27:2881–2885
Marvit J, DiLella AG, Brayton K, Ledley FD, Robson KJH, Woo SLC (1987) GT to AT transition at a splice site donor site causes skipping of the preceding exon in phenylketonuria. Nucl Acids Res 15:5613–5628
Okano Y, Wang T, Eisensmith RC, Güttler F, Woo SLC (1990) Recurrent mutation in the human phenylalanine hydroxylase gene, Am J Hum Genet 46:919–924
Okano Y, Wang T, Eisensmith RC, Steinmann B, Gitzelmann R, Woo SLC (1990) Missense mutations associated with RFLP haplotypes 1 and 4 of the human phenylalanine hydroxylase gene. Am J Hum Genet 46:18–25
Okano Y, Eisensmith RC, Dasovich M, Wang T, Güttler F, Woo SLC (1991) A prevalent missense mutation in Northern Europe associated with hyperphenylalaninemia. Eur J Pediatr 150:347–352
Okano Y, Eisensmith RC, Güttler F, Lichter-Konecki U, Konecki D, Trefz FK, Dasovich M, Wang T, Henriksen K, Lou H, Woo SLC (1991) Molecular basis of phenotypic heterogeneity in phenylketonuria. N Engl J Med 324:1232–1238
Okano Y, Wang T, Eisensmith RC, Longhi R, Giovanni M, Cerone R, Romano C, Woo SLC (1991) Phenylketonuria missense mutations in the Mediterranean. Genomics 9:96–103
Scriver CR, Kaufman S, Woo SLC (1989) The hyperphenylalaninemias. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic basis of inherited disease, 6th edn. McGraw Hill, New York, p 513
Svensson E, Andersson B, Hagenfeldt L (1990) Two mutations within the coding sequence of the phenylalanine hydroxase gene. Hum Genet 85:300–304
Svensson E, Döbeln U von, Hagenfeldt L (1991) Polymorphic DNA haplotpyes at the phenylalanine hydroxylase locus and their relation to phenotype in Swedish phenylketonuria families. Hum Genet 87:11–17
Svensson E, Eisensmith RC, Dworniczak B, von Döbeln U, Hagenfeldt L, Horst J, Woo SLC (1992) Two missense mutations causing hyperphenylalaninemia associated with DNA haplotype 12. Hum Mutation (in press)
Wang T, Okano Y, Eisensmith RC, Fekete G, Schuler D, Berensci G, Nasz I, Woo SLC (1990) Molecular genetic of PKU in Eastern Europe: A nonsense mutation associated with haplotype 4 of the phenylalanine hydroxylase gene. Somat Cell Mol Genet 16:85–90
Wang T, Okano Y, Eisensmith RC, Lo WHY, Huang S-Z, Zeng Y-T, Yuan L-F, Liu S-R, Woo SLC (1991) Missense mutations prevalent in Orientals with phenylketonuria: Molecular characterization and clinical implications Genomics 10:449–456
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Svensson, E., von Döbeln, U., Eisensmith, R.C. et al. Relation between genotype and phenotype in Swedish phenylketonuria and hyperphenylalaninemia patients. Eur J Pediatr 152, 132–139 (1993). https://doi.org/10.1007/BF02072490
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02072490